PROPOSED PLACING OF SHARES IN PAXMAN AB (PUBL)
Reading Time: 4 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT
Completed sale of shares in Eastnine AB
Reading Time: 6 minutes December 5, 2024 THIS PRESS RELEASE IS FOR THE USE OF THE INTENDED RECIPIENT ONLY AND SHOULD NOT BE COPIED OR DISTRIBUTED TO ANY OTHER PERSON. NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WHOLLY OR PARTLY, IN OR INTO THE U.S. (OR TO
Nordea Bank Abp: Repurchase of own shares on 05.12.2024
Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares05.12.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 05.12.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average
RESULTS OF PROPOSED PLACING OF SHARES IN PAXMAN AB (PUBL)
Reading Time: 4 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT
Contemplated sale of shares in Eastnine AB
Reading Time: 6 minutes 5 December 2024 THIS PRESS RELEASE IS FOR THE USE OF THE INTENDED RECIPIENT ONLY AND SHOULD NOT BE COPIED OR DISTRIBUTED TO ANY OTHER PERSON. NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WHOLLY OR PARTLY, IN OR INTO THE U.S. (OR TO
Grant of warrants – Impero A/S
Reading Time: 2 minutes Company Announcement No. 14-2024 Copenhagen, 5 December 2024 Today, Impero’s Board of Directors has decided to exercise its current authorization in section 4.8 of the Articles of Association by issuing 258,000 new warrants to key employees in the Company. The warrants
#24-419 Delisting of Derivatives from NGM
Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Observe Medical ASA: Final result of the subsequent offering and allocation of shares; Updated amendments of loans from Navamedic ASA to be implemented including partial conversion to shares
Reading Time: 7 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT
Hansa Biopharma Completes Enrolment in Global Pivotal Phase 3 Trial of imlifidase in Anti-Glomerular Basement Membrane Disease
Reading Time: 4 minutes Data from the trial is expected to be shared in 2025 Lund, Sweden, 5 December 2024. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA) today announced it has completed the enrolment of patients in the GOOD-IDES-02 trial, a global pivotal Phase 3 trial
Japan Credit Rating Agency awards SMFG India Credit AA- Rating, 4 Notches Above India’s Sovereign Rating
Reading Time: 2 minutes SMFG India Credit (SMICC), a wholly-owned subsidiary of Sumitomo Mitsui Financial Group (SMFG), has been awarded an international credit rating of “AA-” with a stable outlook by the Japan Credit Rating Agency (JCR). This exceptional outcome places SMICC four notches above India’s sovereign rating and